LU87843A1 - Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique - Google Patents

Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique Download PDF

Info

Publication number
LU87843A1
LU87843A1 LU87843A LU87843A LU87843A1 LU 87843 A1 LU87843 A1 LU 87843A1 LU 87843 A LU87843 A LU 87843A LU 87843 A LU87843 A LU 87843A LU 87843 A1 LU87843 A1 LU 87843A1
Authority
LU
Luxembourg
Prior art keywords
gel
weight
retinoic acid
proportion
gel according
Prior art date
Application number
LU87843A
Other languages
English (en)
French (fr)
Original Assignee
Cird Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird Galderma filed Critical Cird Galderma
Priority to LU87843A priority Critical patent/LU87843A1/fr
Priority to ES91403059T priority patent/ES2064958T3/es
Priority to EP91403059A priority patent/EP0486395B1/fr
Priority to DK91403059.8T priority patent/DK0486395T3/da
Priority to DE69105094T priority patent/DE69105094T2/de
Priority to AT91403059T priority patent/ATE113831T1/de
Priority to CA002055578A priority patent/CA2055578A1/fr
Priority to JP3300250A priority patent/JP2650805B2/ja
Publication of LU87843A1 publication Critical patent/LU87843A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU87843A 1990-11-15 1990-11-15 Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique LU87843A1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
LU87843A LU87843A1 (fr) 1990-11-15 1990-11-15 Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique
ES91403059T ES2064958T3 (es) 1990-11-15 1991-11-14 Gel acuoso a base de acido retinoico y de hidroxipropil-beta-ciclodextrina.
EP91403059A EP0486395B1 (fr) 1990-11-15 1991-11-14 Gel aqueux à base d'acide rétinoique et d'hydroxypropyl-bêta-cyclodextrine
DK91403059.8T DK0486395T3 (da) 1990-11-15 1991-11-14 Vandig gel på basis af retinoesyre og hydroxypropyl-beta-cyclodextrin
DE69105094T DE69105094T2 (de) 1990-11-15 1991-11-14 Wässriges Gel von Retinsäure und Hydroxypropyl-beta-Zyklodextrin.
AT91403059T ATE113831T1 (de) 1990-11-15 1991-11-14 Wässriges gel von retinsäure und hydroxypropyl- beta-zyklodextrin.
CA002055578A CA2055578A1 (fr) 1990-11-15 1991-11-14 Gel aqueux a base d'acide retinoique et d'hydroxypropyl-.beta.-cyclodex trine et son utilisation en medecine humaine et en cosmetique
JP3300250A JP2650805B2 (ja) 1990-11-15 1991-11-15 レチノイン酸及びヒドロキシプロピル−β−シクロデキストリンを基質とする水性ゲル

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU87843A LU87843A1 (fr) 1990-11-15 1990-11-15 Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique

Publications (1)

Publication Number Publication Date
LU87843A1 true LU87843A1 (fr) 1992-08-25

Family

ID=19731263

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87843A LU87843A1 (fr) 1990-11-15 1990-11-15 Gel aqueux a base d'acide retinoique et d'hydroxypropyl-beta-cyclodextrine et son utilisation en medecine humaine et en cosmetique

Country Status (8)

Country Link
EP (1) EP0486395B1 (ja)
JP (1) JP2650805B2 (ja)
AT (1) ATE113831T1 (ja)
CA (1) CA2055578A1 (ja)
DE (1) DE69105094T2 (ja)
DK (1) DK0486395T3 (ja)
ES (1) ES2064958T3 (ja)
LU (1) LU87843A1 (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2047456B1 (es) * 1992-07-31 1994-10-01 Herrando Carlos Postigo Composicion para la obtencion de un producto cosmetico y productos similares.
SE9300971D0 (sv) * 1993-03-24 1993-03-24 Jan Wadstein Hudvaardskomposition
ES2083333B1 (es) * 1994-09-22 1997-01-16 Corral Begona Gozalo Crema para el tratamiento de la psoriasis.
IL131543A (en) 1997-02-25 2005-08-31 Univ Michigan Cosmetic methods and compositions for preventing and treating chronological aging in human skin
WO1998050012A1 (en) * 1997-05-02 1998-11-12 Gist-Brocades B.V. Stable vitamin c concentrates
EP1109581A1 (en) * 1998-09-02 2001-06-27 Allergan Sales, Inc. Preserved cyclodextrin-containing compositions
JP2006510652A (ja) * 2002-12-12 2006-03-30 ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ フェノール誘導体およびレチノイド含有水−アルコール脱色ゲル
JP4781680B2 (ja) * 2005-01-17 2011-09-28 株式会社Ａｄｅｋａ 防腐剤組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8910069D0 (en) * 1989-05-03 1989-06-21 Janssen Pharmaceutica Nv Method of topically treating acne vulgaris
FR2647015B1 (fr) * 1989-05-17 1994-05-06 Cird Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique

Also Published As

Publication number Publication date
JP2650805B2 (ja) 1997-09-10
ATE113831T1 (de) 1994-11-15
CA2055578A1 (fr) 1992-05-16
DE69105094D1 (de) 1994-12-15
ES2064958T3 (es) 1995-02-01
JPH0656622A (ja) 1994-03-01
DK0486395T3 (da) 1995-04-24
EP0486395B1 (fr) 1994-11-09
DE69105094T2 (de) 1995-05-18
EP0486395A1 (fr) 1992-05-20

Similar Documents

Publication Publication Date Title
CA2466321C (fr) Gel comprenant au moins un retinoide et du peroxyde de benzoyle
EP2460562B1 (fr) Gel-crème comprenant au moins un rétinoïde et du péroxyde de benzoyle
EP1438015B1 (fr) Compositions cosmetiques et dermopharmaceutiques pour les peaux a tendance acneique
EP2125117B1 (fr) Emulsion comprenant au moins un retinoide et du péroxyde de benzoyle
EP0472225A2 (fr) Liposomes ou phases lamellaires lipidiques hydratées contenant de la trétinoine
CA2670599A1 (fr) Compositions comprenant du peroxyde de benzoyle, au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethane ou des derives de celui-ci, et leurs utilisations
EP0771557B1 (fr) Utilisation de l'acide ascorbique comme actif pour le traitement de la séborrhée dans une composition cosmétique et/ou dermatologique
CA2706655A1 (fr) Compositions comprenant au moins un derive de l'acide naphtoique, du peroxyde de benzoyle et au moins un agent filmogene, leurs procedes de preparation, et leurs ulitisations
FR2901139A1 (fr) Compositions comprenant au moins un derive de l'acide naphtoique et du peroxyde de benzoyle, leurs procedes de preparation, et leurs utilisations
WO1990014082A1 (fr) Gel aqueux a base d'acide retinoique
EP2240152B1 (fr) Composition comprenant un retinoide et du peroxyde de benzoyle disperse
EP0486395B1 (fr) Gel aqueux à base d'acide rétinoique et d'hydroxypropyl-bêta-cyclodextrine
FR2462424A1 (fr) Composition a base de peroxyde de benzyle, notamment pour le traitement de l'acne
EP2167016B1 (fr) Hydrogel de carboxyalkylamide de chitosan, sa preparation et son utilisation cosmetique et dermatologique
FR2946249A1 (fr) Compositions topiques depigmentantes, et leurs utilisations.
FR2894474A1 (fr) Gel depigmentant hydroalcoolique
FR2901701A1 (fr) Compostions comprenant au moins un derive de l'acide naphtoique et au moins un agent filmogene, leurs procedes de preparation, et leurs utilisations
CH670951A5 (en) Cosmetic, cicatrising and disinfectant emulsions - contain vitamin=A ester and hydrogen peroxide
EP0350438B1 (fr) Composition à usage cosmétique ou pharmaceutique
FR2793410A1 (fr) Utilisation de lipides peroxydes comme agents destines a prevenir et/ou a traiter les effets irritants d'un principe actif
CN115919682A (zh) 一种包裹超分子控油抑菌组合物、制备方法及其应用